Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma. - Hou, Changlong; Xiong, Baizhu; Zhou, Lei; Fei, Yipeng; Shi, Changgao; Zhu, Xianhai; Xie, Tao; Wu, Yulin (BMC Cancer, 2024)